This review summarizes the pathophysiology, diagnosis, and treatment of atrial fibrillation in the context of the 2016 European guidelines.
Answers are grounded in this paper and cite their sources.
May aid AF management review against 2016 standards; leaves open integration of subsequent trial data.
Atrial fibrillation is association a wide range of genetic, metabolic, and environmental causes. The number of patients with atrial fibrillation is increasing exponentially, predominantly due to aging and a variety of heart conditions such as ischemic heart disease and heart failure. Owing to a range of unmet clinical and social needs, atrial fibrillation has become a significant target for research studies. Thus far, research has revealed several important mechanisms related to the pathophysiology, diagnostic, and optimal treatment of atrial fibrillation. In this review, we aim to summarize the current status of research on atrial fibrillation and relate such progress to the European Atrial Fibrillation Guidelines (2016).
No takes yet. Share an insight, caveat, or question.
Seung Yong Shin (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: